These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25226518)

  • 21. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy.
    Fidarova EF; El-Emir E; Boxer GM; Qureshi U; Dearling JL; Robson MP; Begent RH; Trott KR; Pedley RB
    Clin Cancer Res; 2008 May; 14(9):2639-46. PubMed ID: 18451227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models.
    Turner MA; Amirfakhri S; Nishino H; Neel NC; Hosseini M; Cox KE; Lwin TM; Li L; Hong T; Sherman A; Shively JE; Hoffman RM; Yazaki PJ; Bouvet M
    J Surg Res; 2023 Nov; 291():596-602. PubMed ID: 37540977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibodies].
    Murayama H; Watanabe T; Sakamoto J; Tadokoro M; Takagi H; Sakuma S
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1732-41. PubMed ID: 2594001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of Copper-64-Based Host-Guest Chemistry Pretargeted Positron Emission Tomography.
    Jallinoja VIJ; Carney BD; Bhatt K; Abbriano CH; Schlyer DJ; Yazaki PJ; Houghton JL
    Mol Pharm; 2022 Jul; 19(7):2268-2278. PubMed ID: 35700402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
    Yazaki PJ; Wu AM; Tsai SW; Williams LE; Ikler DN; Wong JY; Shively JE; Raubitschek AA
    Bioconjug Chem; 2001; 12(2):220-8. PubMed ID: 11312683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer.
    Ychou M; Pelegrin A; Faurous P; Robert B; Saccavini JC; Guerreau D; Rossi JF; Fabbro M; Buchegger F; Mach JP; Artus JC
    Int J Cancer; 1998 Feb; 75(4):615-9. PubMed ID: 9466665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoradiographic analysis of radiolabeled anti-carcinoembryonic antigen monoclonal antibody CEA102 in colorectal cancer using computed radiography.
    Satoh T; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Itoh K; Sakuma S; Takagi H
    Jpn J Cancer Res; 1992 Apr; 83(4):379-86. PubMed ID: 1506272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ionic charge of copper-64 complexes conjugated to an engineered antibody affects biodistribution.
    Dearling JL; Paterson BM; Akurathi V; Betanzos-Lara S; Treves ST; Voss SD; White JM; Huston JS; Smith SV; Donnelly PS; Packard AB
    Bioconjug Chem; 2015 Apr; 26(4):707-17. PubMed ID: 25719414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.
    O'Neill AF; Dearling JL; Wang Y; Tupper T; Sun Y; Aster JC; Calicchio ML; Perez-Atayde AR; Packard AB; Kung AL
    Clin Cancer Res; 2014 Feb; 20(3):678-87. PubMed ID: 24218512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake.
    Dearling JL; Flynn AA; Qureshi U; Whiting S; Boxer GM; Green A; Begent RH; Pedley RB
    Nucl Med Biol; 2009 Nov; 36(8):883-94. PubMed ID: 19875045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor targeting with radiolabeled antibodies in a human carcinoembryonic antigen transgenic mouse model.
    Szalai G; Williams LE; Primus FJ
    Int J Cancer; 2000 Mar; 85(6):751-6. PubMed ID: 10709090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of specific accumulation of radiolabeled anti-carcinoembryonic antigen monoclonal antibody CEA 102 in colorectal cancer using computed radiography.
    Watanabe T; Satoh T; Tadokoro M; Sakamoto J; Murayama H; Itoh K; Sakuma S; Takagi H
    Cancer Detect Prev; 1997; 21(4):346-54. PubMed ID: 9232326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.
    Wu AM; Yazaki PJ; Tsai Sw; Nguyen K; Anderson AL; McCarthy DW; Welch MJ; Shively JE; Williams LE; Raubitschek AA; Wong JY; Toyokuni T; Phelps ME; Gambhir SS
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8495-500. PubMed ID: 10880576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioimmunoimaging of non-small cell lung cancer with 111In- and 99mTc-labeled monoclonal anti-CEA-antibodies.
    Kairemo KJ; Aronen HJ; Liewendahl K; Paavonen T; Heikkonen JJ; Virkkunen P; Mäki-Hokkonen H; Karonen SL; Brownell AL; Mäntylä MJ
    Acta Oncol; 1993; 32(7-8):771-8. PubMed ID: 8305225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
    Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
    Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody Targeted PET Imaging of
    Wong P; Li L; Chea J; Hu W; Poku E; Ebner T; Bowles N; Wong JYC; Yazaki PJ; Sligar S; Shively JE
    Bioconjug Chem; 2020 Mar; 31(3):743-753. PubMed ID: 31961138
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Mohajershojai T; Jha P; Boström A; Frejd FY; Yazaki PJ; Nestor M
    Front Oncol; 2022; 12():849338. PubMed ID: 35433442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.
    Hall MA; Pinkston KL; Wilganowski N; Robinson H; Ghosh P; Azhdarinia A; Vazquez-Arreguin K; Kolonin AM; Harvey BR; Sevick-Muraca EM
    J Nucl Med; 2012 Sep; 53(9):1427-37. PubMed ID: 22872743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.